These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23564046)

  • 1. Application of the revised Tumour Node Metastasis (TNM) staging system of clear cell renal cell carcinoma in eastern China: advantages and limitations.
    Qin C; Sun LJ; Cui L; Cao Q; Zhu J; Li P; Zhang GM; Mao X; Shao PF; Wang ML; Zhang ZD; Gu M; Zhang W; Yin CJ
    Asian J Androl; 2013 Jul; 15(4):550-7. PubMed ID: 23564046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
    Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
    BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical Resection.
    Gershman B; Moreira DM; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Aug; 72(2):300-306. PubMed ID: 28094055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology.
    Zigeuner R; Hutterer G; Chromecki T; Imamovic A; Kampel-Kettner K; Rehak P; Langner C; Pummer K
    Eur Urol; 2010 Jan; 57(1):102-9. PubMed ID: 19062157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system.
    Belldegrun A; Tsui KH; deKernion JB; Smith RB
    J Clin Oncol; 1999 Sep; 17(9):2868-75. PubMed ID: 10561364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012.
    Zhang Y; Yu H; Li H
    Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3a.
    Shah PH; Moreira DM; Patel VR; Gaunay G; George AK; Alom M; Kozel Z; Yaskiv O; Hall SJ; Schwartz MJ; Vira MA; Richstone L; Kavoussi LR
    J Urol; 2017 Aug; 198(2):289-296. PubMed ID: 28274620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinoma.
    Eisenberg MS; Cheville JC; Thompson RH; Kaushik D; Lohse CM; Boorjian SA; Costello BA; Leibovich BC
    J Urol; 2013 Jul; 190(1):37-43. PubMed ID: 23353044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.
    Gettman MT; Blute ML; Spotts B; Bryant SC; Zincke H
    Cancer; 2001 Jan; 91(2):354-61. PubMed ID: 11180082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC).
    Capitanio U; Suardi N; Matloob R; Roscigno M; Abdollah F; Di Trapani E; Moschini M; Gallina A; Salonia A; Briganti A; Montorsi F; Bertini R
    BJU Int; 2014 Aug; 114(2):210-5. PubMed ID: 24854206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
    J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
    Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
    Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma.
    Pichler M; Hutterer GC; Chromecki TF; Jesche J; Kampel-Kettner K; Groselj-Strele A; Hoefler G; Pummer K; Zigeuner R
    Histopathology; 2013 Jan; 62(2):237-46. PubMed ID: 23020176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
    Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
    BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of Positive Lymph Nodes in Patients with Renal Cell Carcinoma and Tumor Thrombus Undergoing Nephrectomy and Thrombectomy.
    Xiao R; Xu C; Ge L; He W; Yang B; Liu L; Liu C; Ma L
    Urol Int; 2021; 105(7-8):657-665. PubMed ID: 33882508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional tumour volume and cancer-specific survival for patients undergoing nephrectomy to treat pT1 clear-cell renal cell carcinoma.
    Jorns J; Thiel DD; Lohse CM; Williams A; Arnold ML; Cheville JC; Leibovich BC; Parker AS
    BJU Int; 2012 Oct; 110(7):956-60. PubMed ID: 22300498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.